{"id":6564,"date":"2026-06-29T16:10:51","date_gmt":"2026-06-29T16:10:51","guid":{"rendered":"https:\/\/regenerated.health\/pcos-insulin-resistance\/"},"modified":"2026-06-29T16:10:51","modified_gmt":"2026-06-29T16:10:51","slug":"pcos-insulin-resistance","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/pcos-insulin-resistance\/","title":{"rendered":"PCOS and Insulin Resistance: The Metabolic Connection"},"content":{"rendered":"

The short answer:<\/strong> Insulin resistance sits at the metabolic centre of polycystic ovary syndrome (PCOS) for most people who have it. When cells respond poorly to insulin, the pancreas compensates by releasing more, and that excess insulin pushes the ovaries to make extra androgens while lowering the protein that keeps androgens in check. The result is a self-reinforcing loop that drives many PCOS symptoms. The good news is that this loop responds to treatment. Targeted nutrition, movement, and where appropriate medications such as metformin, inositol supplements, or GLP-1 receptor agonists can all help, ideally under a clinician’s guidance.<\/p>\n

How insulin resistance and PCOS are connected<\/h2>\n

Insulin is the hormone that moves glucose from your blood into cells for energy. In insulin resistance, muscle, liver, and fat tissue stop responding to it efficiently. To keep blood sugar normal, the pancreas secretes more insulin, a state called hyperinsulinemia. This is common in PCOS, affecting a large share of people with the condition across body sizes, including some who are lean.<\/p>\n

The connection is not just an association. Insulin acts directly on the ovaries. It stimulates an enzyme called cytochrome P450c17 that increases androgen production in the ovarian theca cells. At the same time, high insulin reduces the liver’s output of sex hormone-binding globulin (SHBG), the protein that binds testosterone and keeps it inactive. Less SHBG means more free, active testosterone circulating. This is why irregular cycles, acne, and excess hair growth often track with metabolic markers.<\/p>\n

Researchers increasingly describe this as a vicious cycle rather than a one-way street. Androgens themselves can worsen insulin resistance by altering fat distribution and muscle function, which then raises insulin further. A 2025 review in the Journal of Endocrinology<\/em> noted that hyperinsulinemia can even appear in some people before measurable insulin resistance, suggesting androgens may directly nudge the pancreas to oversecrete insulin. The takeaway for everyday life is simpler than the biology: addressing insulin tends to ease the whole system.<\/p>\n

\n\n\n\n\n\n\n\n\n\n
Step in the loop<\/th>\nWhat happens<\/th>\n<\/tr>\n<\/thead>\n
Insulin resistance<\/td>\nCells respond poorly to insulin<\/td>\n<\/tr>\n
Hyperinsulinemia<\/td>\nPancreas releases more insulin to compensate<\/td>\n<\/tr>\n
Ovarian effect<\/td>\nExcess insulin raises androgen production<\/td>\n<\/tr>\n
Liver effect<\/td>\nSHBG drops, so more free testosterone circulates<\/td>\n<\/tr>\n
Symptoms<\/td>\nIrregular periods, acne, excess hair growth<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

How insulin resistance is tested in PCOS<\/h2>\n

This is an area where expectations and clinical reality differ. The 2023 International Evidence-based Guideline for the Assessment and Management of PCOS<\/strong> is clear that direct insulin testing is not recommended in routine care. Fasting insulin and HOMA-IR (a calculation using fasting glucose and insulin) are used heavily in research, but the assays are not standardised enough to guide individual treatment reliably.<\/p>\n

Instead, the guideline recommends assessing glucose metabolism and overall metabolic risk. Practical tests your clinician may order include:<\/p>\n